From guidelines to evidence-based practice - A German perspective on mesalazine as first-line therapy for mild-to-moderate ulcerative colitis.

Schnoy E, Dignass A, Gaskins M, Kucharzik T

Open source

DOI
10.1055/a-2596-8934
Published
2025 Oct
Container
Zeitschrift fur Gastroenterologie
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1055/a-2596-8934,
  title = {From guidelines to evidence-based practice - A German perspective on mesalazine as first-line therapy for mild-to-moderate ulcerative colitis.},
  author = {Schnoy E and Dignass A and Gaskins M and Kucharzik T},
  year = {2025},
  journal = {Zeitschrift fur Gastroenterologie},
  doi = {10.1055/a-2596-8934},
  url = {https://doi.org/10.1055/a-2596-8934}
}

RIS

TY  - JOUR
TI  - From guidelines to evidence-based practice - A German perspective on mesalazine as first-line therapy for mild-to-moderate ulcerative colitis.
AU  - Schnoy E
AU  - Dignass A
AU  - Gaskins M
AU  - Kucharzik T
PY  - 2025
JO  - Zeitschrift fur Gastroenterologie
DO  - 10.1055/a-2596-8934
UR  - https://doi.org/10.1055/a-2596-8934
ER  - 

APA

E, S., A, D., M, G., & T, K. (2025). From guidelines to evidence-based practice - A German perspective on mesalazine as first-line therapy for mild-to-moderate ulcerative colitis.. Zeitschrift fur Gastroenterologie. https://doi.org/10.1055/a-2596-8934

Source records